ArticleContemporary clinical trials communications2024

Efficacy, safety, and response predictors of Astragalus in patients with mild to moderate Alzheimer's disease: A study protocol of an assessor-blind, statistician-blind open-label randomized controlled trial.

Yingzhe Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.